Cambridge Financial Group Inc. Sells 2,806 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cambridge Financial Group Inc. trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 181,768 shares of the pharmacy operator’s stock after selling 2,806 shares during the quarter. Walgreens Boots Alliance makes up 2.4% of Cambridge Financial Group Inc.’s portfolio, making the stock its 29th biggest position. Cambridge Financial Group Inc.’s holdings in Walgreens Boots Alliance were worth $4,746,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its holdings in shares of Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 845 shares in the last quarter. Highlander Capital Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $26,000. Venturi Wealth Management LLC grew its holdings in Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares during the last quarter. FinTrust Capital Advisors LLC grew its holdings in Walgreens Boots Alliance by 2,314.5% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,273 shares during the last quarter. Finally, Rocky Mountain Advisers LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at approximately $30,000. 58.59% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Inderpal S. Bhandari purchased 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Manmohan Mahajan acquired 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were bought at an average price of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on WBA. Bank of America lowered their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Deutsche Bank Aktiengesellschaft lowered their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Finally, UBS Group cut their target price on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $24.36.

Walgreens Boots Alliance Stock Up 1.6 %

WBA traded up $0.28 during midday trading on Friday, reaching $17.81. 7,528,623 shares of the company were exchanged, compared to its average volume of 10,049,602. Walgreens Boots Alliance, Inc. has a one year low of $17.25 and a one year high of $32.89. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The company’s fifty day moving average price is $19.59 and its 200 day moving average price is $21.58. The company has a market cap of $15.36 billion, a price-to-earnings ratio of -2.54, a price-to-earnings-growth ratio of 1.10 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.16 EPS. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 5.61%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.